141 related articles for article (PubMed ID: 38870290)
21. Impact of SGLT-2 Inhibition on Cardiometabolic Abnormalities in a Rat Model of Polycystic Ovary Syndrome.
Pruett JE; Torres Fernandez ED; Everman SJ; Vinson RM; Davenport K; Logan MK; Ye SA; Romero DG; Yanes Cardozo LL
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33806551
[TBL] [Abstract][Full Text] [Related]
22. Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty.
Blank SK; McCartney CR; Helm KD; Marshall JC
Semin Reprod Med; 2007 Sep; 25(5):352-9. PubMed ID: 17710731
[TBL] [Abstract][Full Text] [Related]
23. N6-methyladenosine demethylase FTO related to hyperandrogenism in PCOS via AKT pathway.
Jing YX; Li HX; Yue F; Li YM; Yu X; He JJ; Zhang XH
Gynecol Endocrinol; 2023 Oct; 39(1):2276167. PubMed ID: 37931646
[TBL] [Abstract][Full Text] [Related]
24. Adipocyte and steroidogenic cell cross-talk in polycystic ovary syndrome.
de Medeiros SF; Rodgers RJ; Norman RJ
Hum Reprod Update; 2021 Jun; 27(4):771-796. PubMed ID: 33764457
[TBL] [Abstract][Full Text] [Related]
25. Effects of electroacupuncture on the kisspeptin-gonadotropin-releasing hormone (GnRH) /luteinizing hormone (LH) neural circuit abnormalities and androgen receptor expression of kisspeptin/neurokinin B/dynorphin neurons in PCOS rats.
Xu G; Zhao X; Li Z; Hu J; Li X; Li J; Chen Y
J Ovarian Res; 2023 Jan; 16(1):15. PubMed ID: 36650561
[TBL] [Abstract][Full Text] [Related]
26. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.
Rosenfield RL; Ehrmann DA
Endocr Rev; 2016 Oct; 37(5):467-520. PubMed ID: 27459230
[TBL] [Abstract][Full Text] [Related]
27. A Review on
Heidarzadehpilehrood R; Pirhoushiaran M; Abdollahzadeh R; Binti Osman M; Sakinah M; Nordin N; Abdul Hamid H
Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205347
[TBL] [Abstract][Full Text] [Related]
28. Dehydroepiandrosterone stimulates inflammation and impairs ovarian functions of polycystic ovary syndrome.
Li Y; Zheng Q; Sun D; Cui X; Chen S; Bulbul A; Liu S; Yan Q
J Cell Physiol; 2019 May; 234(5):7435-7447. PubMed ID: 30580448
[TBL] [Abstract][Full Text] [Related]
29. Adiponectin and its receptors in the ovary: further evidence for a link between obesity and hyperandrogenism in polycystic ovary syndrome.
Comim FV; Hardy K; Franks S
PLoS One; 2013; 8(11):e80416. PubMed ID: 24260388
[TBL] [Abstract][Full Text] [Related]
30.
Yanes Cardozo LL; Romero DG; Reckelhoff JF
Physiology (Bethesda); 2017 Sep; 32(5):357-366. PubMed ID: 28814496
[TBL] [Abstract][Full Text] [Related]
31. Investigating GABA Neuron-Specific Androgen Receptor Knockout in two Hyperandrogenic Models of PCOS.
Sucquart IE; Coyle C; Rodriguez Paris V; Prescott M; Glendining KA; Potapov K; Begg DP; Gilchrist RB; Walters KA; Campbell RE
Endocrinology; 2024 May; 165(7):. PubMed ID: 38788194
[TBL] [Abstract][Full Text] [Related]
32. Retinoids and retinol differentially regulate steroid biosynthesis in ovarian theca cells isolated from normal cycling women and women with polycystic ovary syndrome.
Wickenheisser JK; Nelson-DeGrave VL; Hendricks KL; Legro RS; Strauss JF; McAllister JM
J Clin Endocrinol Metab; 2005 Aug; 90(8):4858-65. PubMed ID: 15914525
[TBL] [Abstract][Full Text] [Related]
33. Androgen signaling pathways driving reproductive and metabolic phenotypes in a PCOS mouse model.
Aflatounian A; Edwards MC; Rodriguez Paris V; Bertoldo MJ; Desai R; Gilchrist RB; Ledger WL; Handelsman DJ; Walters KA
J Endocrinol; 2020 Jun; 245(3):381-395. PubMed ID: 32229702
[TBL] [Abstract][Full Text] [Related]
34. Fetal programming by androgen excess in rats affects ovarian fuel sensors and steroidogenesis.
Abruzzese GA; Heber MF; Campo Verde Arbocco F; Ferreira SR; Motta AB
J Dev Orig Health Dis; 2019 Dec; 10(6):645-658. PubMed ID: 31122307
[TBL] [Abstract][Full Text] [Related]
35. The effect of ellagic acid on sex hormones and miRNA-21 expression in rats with polycystic ovary syndrome.
Khoshvaghti A; Rahbari R
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4263-4273. PubMed ID: 38078918
[TBL] [Abstract][Full Text] [Related]
36. Linum usitatissimum seeds oil down-regulates mRNA expression for the steroidogenic acute regulatory protein and Cyp11A1 genes, ameliorating letrezole-induced polycystic ovarian syndrome in a rat model.
Emam SR; Abd-Elsalam RM; Azouz AA; Ali SE; El Badawy SA; Ibrahim MA; Hassan BB; Issa MY; Elmosalamy SH
J Physiol Pharmacol; 2021 Feb; 72(1):. PubMed ID: 34099585
[TBL] [Abstract][Full Text] [Related]
37. Dulaglutide, a long-acting GLP-1 receptor agonist, can improve hyperandrogenemia and ovarian function in DHEA-induced PCOS rats.
Wu LM; Wang YX; Zhan Y; Liu AH; Wang YX; Shen HF; Wang YF; Wang LY; Tao ZB; Wang YQ
Peptides; 2021 Nov; 145():170624. PubMed ID: 34375684
[TBL] [Abstract][Full Text] [Related]
38. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
[TBL] [Abstract][Full Text] [Related]
39. Androgen circle of polycystic ovary syndrome.
Homburg R
Hum Reprod; 2009 Jul; 24(7):1548-55. PubMed ID: 19279033
[TBL] [Abstract][Full Text] [Related]
40. Disuse-associated loss of the protease LONP1 in muscle impairs mitochondrial function and causes reduced skeletal muscle mass and strength.
Xu Z; Fu T; Guo Q; Zhou D; Sun W; Zhou Z; Chen X; Zhang J; Liu L; Xiao L; Yin Y; Jia Y; Pang E; Chen Y; Pan X; Fang L; Zhu MS; Fei W; Lu B; Gan Z
Nat Commun; 2022 Feb; 13(1):894. PubMed ID: 35173176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
